摘要
目的:观察稳心颗粒及比索洛尔治疗扩张型心疾病心律失常临床疗效。方法:选择150例扩张型心肌病的患者,随机分为3组,每组50例。联合治疗组:口服稳心颗粒及比索洛尔;稳心颗粒组:口服稳心颗粒;比索洛尔组:口服比索洛尔。3组治疗时间均为4周,分别观察治疗前后临床症状及动态心电图。结果:联合治疗组总有效率90%/88%;稳心颗粒组总有效率74%/74%;比索洛尔组总有效率76%/78%。经统计学处理,3组中联合治疗组总有效率与稳心颗粒组和比索洛尔组比较差异有统计学意义,(P<0.05)。结论:稳心颗粒联用比索洛尔治疗扩张型心肌病心律失常比单用稳心颗粒和比索洛尔效果好。
Objective：To observe cardiomyopathy of Wenxinkeli and bisoprolol treating dilated heart disease with arrhythmia. Methods： 150 cases of dilated cardiomyopathy patients were randomly divided into 3 groups. Combined treatment groups： oral Wenxinkeli and bisoprolol;Wenxinkeli groups： oral Wenxinkeli;bisoprolol group： oral Bisoprolol. The treatment time was before and after treatment the clinical symptoms and Holter monitoring. Results ： The combination therapy group, the total efficiency was 90% / 88% ;Wenxinkeli total effective rate was 74% / 74% ;bisoprolol group,the total efficiency was 76% / 78%. Statistically, the total efficiency and stability of the heart in the combined treatment group were statistically different from those in Bisoprolol tablets group and the Wenxinkeli group （ P 〈 0. 05 ）. Conclusion ： Wenxinkeli combined with bisoprolol treating dilated eardiomyopathy, arrhythmia than a single Bisoprolol with Wenxinkeli and effect.
出处
《辽宁中医杂志》
CAS
2012年第2期305-306,共2页
Liaoning Journal of Traditional Chinese Medicine
作者简介
刘熠（1964-），男，副主任医师，研究方向：心血管内科。
